Comparison of Pain of Two Different Methods in Uterine Artery Embolization
Primary Purpose
Leiomyoma
Status
Completed
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Non-spherical polyvinyl alcohol particle or Tris-acryl gelatin microsphere
Sponsored by
About this trial
This is an interventional prevention trial for Leiomyoma
Eligibility Criteria
Inclusion Criteria:
- Uterine artery embolization due to multiple fibroids
Exclusion Criteria:
- Severe liver or kidney dysfunction
- Drug allergy
- Bradycardia (<45 bpm) or heart block
- Uncontrolled hypertension
Sites / Locations
- Sesverance Hospital, Yonsei University College of Medicine
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Non-spherical polyvinyl alcohol particle
Tris-acryl gelatin microsphere
Arm Description
For embolic material, non-spherical polyvinyl alcohol particle is used.
For embolic material, Tris-acryl gelatin microsphere is used.
Outcomes
Primary Outcome Measures
Pain intensity by numerical rating scale
0-10 numerical rating scale (0, no pain at all; 10, worst pain imaginable
Secondary Outcome Measures
C-reactive protein
mg/L
White blood cell count
/uL
Neutrophil percentage
Neutrophil-to-lymphocyte ratio
Platelet-to-lymphocyte ratio
Mean platelet volume
fL(femtolitre)
Sucessful rate at 3 month after UAE measured by MRI
Complete necrosis incidence
Full Information
NCT ID
NCT03420248
First Posted
January 16, 2018
Last Updated
September 17, 2019
Sponsor
Severance Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03420248
Brief Title
Comparison of Pain of Two Different Methods in Uterine Artery Embolization
Official Title
Comparison of Pain After Uterine Artery Embolization Using Non-spherical Polyvinyl Alcohol Particles or Tris-acryl Gelatin Microsphere in Patients With Symptomatic Fibroids
Study Type
Interventional
2. Study Status
Record Verification Date
September 2019
Overall Recruitment Status
Completed
Study Start Date
April 19, 2018 (Actual)
Primary Completion Date
February 8, 2019 (Actual)
Study Completion Date
May 8, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Severance Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The primary purpose of this study is to compare pain after uterine artery embolization using non-spherical polyvinyl alcohol particles or tris-acryl gelatin microsphere in patients with symptomatic fibroids
Detailed Description
Uterine artery embolization(UAE) is a minimally invasive treatment alternative to hysterectomy and myomectomy in symptomatic fibroids. However, post-procedural pain after UAE remains a major problem. The non-spherical polyvinyl alcohol particle and tri-acryl gelatin microsphere are two embolic materials used for UAE.Therefore, the aim of study is to compare pain intensity and inflammation after uterine artery embolization using non-spherical polyvinyl alcohol particles or tris-acryl gelatin microsphere in patients with symptomatic fibroids
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Leiomyoma
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
54 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Non-spherical polyvinyl alcohol particle
Arm Type
Experimental
Arm Description
For embolic material, non-spherical polyvinyl alcohol particle is used.
Arm Title
Tris-acryl gelatin microsphere
Arm Type
Experimental
Arm Description
For embolic material, Tris-acryl gelatin microsphere is used.
Intervention Type
Device
Intervention Name(s)
Non-spherical polyvinyl alcohol particle or Tris-acryl gelatin microsphere
Intervention Description
One of non-spherical polyvinyl alcohol particle or tris-acryl gelatin microsphere is used for embolic materials. All other processes are same.
Primary Outcome Measure Information:
Title
Pain intensity by numerical rating scale
Description
0-10 numerical rating scale (0, no pain at all; 10, worst pain imaginable
Time Frame
0-24 h after UAE
Secondary Outcome Measure Information:
Title
C-reactive protein
Description
mg/L
Time Frame
24 h after UAE
Title
White blood cell count
Description
/uL
Time Frame
24 h after UAE
Title
Neutrophil percentage
Time Frame
24 h after UAE
Title
Neutrophil-to-lymphocyte ratio
Time Frame
24 h after UAE
Title
Platelet-to-lymphocyte ratio
Time Frame
24 h after UAE
Title
Mean platelet volume
Description
fL(femtolitre)
Time Frame
24 h after UAE
Title
Sucessful rate at 3 month after UAE measured by MRI
Description
Complete necrosis incidence
Time Frame
3 month after UAE
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Uterine artery embolization due to multiple fibroids
Exclusion Criteria:
Severe liver or kidney dysfunction
Drug allergy
Bradycardia (<45 bpm) or heart block
Uncontrolled hypertension
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
So Yeon Kim, MD, PhD
Organizational Affiliation
Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Severance Hospital, Yonsei University College of Medicine
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Man Deuk Kim, MD, PhD
Organizational Affiliation
Department of Radiology, Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sesverance Hospital, Yonsei University College of Medicine
City
Seoul
ZIP/Postal Code
03722
Country
Korea, Republic of
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Comparison of Pain of Two Different Methods in Uterine Artery Embolization
We'll reach out to this number within 24 hrs